Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 10 Neoplasms 3 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 SCLC,Extensive Stage 1 Rare Tumor 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Carcinosarcoma 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Hemangiosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Cystadenocarcinoma, Serous 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Biliary Tract Neoplasms 1 Advanced Solid Tumor 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Carcinosarcoma × niraparib × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡